Overall, our study demonstrates that p62 is a novel substrate of cyclin F. We provide a mechanistic link between cyclin F and p62 regulation, with implications for ALS and FTD pathogenesis. Here, SQSTM1 is linked to amyotrophic lateral sclerosis.